How I manage frontline transplant-ineligible multiple myeloma

The Multiple Myeloma (MM) is a plasma cells hematological malignancy with a median age of 69 years at diagnosis. The autologous stem cell transplantation is the standard of care for this disease but less than half of newly diagnosed patients are assessed for this treatment due to comorbidities or co...

Full description

Bibliographic Details
Main Authors: Daniele Derudas, Francesca Capraro, Giovanni Martinelli, Claudio Cerchione
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Hematology Reports
Subjects:
Online Access:https://www.pagepress.org/journals/index.php/hr/article/view/8956
_version_ 1797936671955615744
author Daniele Derudas
Francesca Capraro
Giovanni Martinelli
Claudio Cerchione
author_facet Daniele Derudas
Francesca Capraro
Giovanni Martinelli
Claudio Cerchione
author_sort Daniele Derudas
collection DOAJ
description The Multiple Myeloma (MM) is a plasma cells hematological malignancy with a median age of 69 years at diagnosis. The autologous stem cell transplantation is the standard of care for this disease but less than half of newly diagnosed patients are assessed for this treatment due to comorbidities or complications of disease. The management of transplant ineligible MM patients is based on the balance safety and efficacy of the new available regimen and a careful assessment of the frailty status is mandatory to define the goals. In this review we discuss of the clinical dilemmas in the management and define how to manage them based on the evidence from clinical trials and “real life” experience.
first_indexed 2024-04-10T18:34:02Z
format Article
id doaj.art-45d0807573a942afa5e04cb68456b69a
institution Directory Open Access Journal
issn 2038-8322
2038-8330
language English
last_indexed 2024-04-10T18:34:02Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Hematology Reports
spelling doaj.art-45d0807573a942afa5e04cb68456b69a2023-02-02T02:23:57ZengMDPI AGHematology Reports2038-83222038-83302020-09-0112s110.4081/hr.2020.8956How I manage frontline transplant-ineligible multiple myelomaDaniele Derudas0Francesca Capraro1Giovanni Martinelli2Claudio Cerchione3S.C. di Ematologia e C.T.M.O. – Ospedale Oncologico di Riferimento Regionale “A. Businco”, Cagliari (CA)S.C. di Ematologia e C.T.M.O. – Ospedale Oncologico di Riferimento Regionale “A. Businco”, Cagliari (CA)Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (FC)Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (FC)The Multiple Myeloma (MM) is a plasma cells hematological malignancy with a median age of 69 years at diagnosis. The autologous stem cell transplantation is the standard of care for this disease but less than half of newly diagnosed patients are assessed for this treatment due to comorbidities or complications of disease. The management of transplant ineligible MM patients is based on the balance safety and efficacy of the new available regimen and a careful assessment of the frailty status is mandatory to define the goals. In this review we discuss of the clinical dilemmas in the management and define how to manage them based on the evidence from clinical trials and “real life” experience.https://www.pagepress.org/journals/index.php/hr/article/view/8956Multiple Myelomatransplant-ineligible
spellingShingle Daniele Derudas
Francesca Capraro
Giovanni Martinelli
Claudio Cerchione
How I manage frontline transplant-ineligible multiple myeloma
Hematology Reports
Multiple Myeloma
transplant-ineligible
title How I manage frontline transplant-ineligible multiple myeloma
title_full How I manage frontline transplant-ineligible multiple myeloma
title_fullStr How I manage frontline transplant-ineligible multiple myeloma
title_full_unstemmed How I manage frontline transplant-ineligible multiple myeloma
title_short How I manage frontline transplant-ineligible multiple myeloma
title_sort how i manage frontline transplant ineligible multiple myeloma
topic Multiple Myeloma
transplant-ineligible
url https://www.pagepress.org/journals/index.php/hr/article/view/8956
work_keys_str_mv AT danielederudas howimanagefrontlinetransplantineligiblemultiplemyeloma
AT francescacapraro howimanagefrontlinetransplantineligiblemultiplemyeloma
AT giovannimartinelli howimanagefrontlinetransplantineligiblemultiplemyeloma
AT claudiocerchione howimanagefrontlinetransplantineligiblemultiplemyeloma